Procept BioRobotics [PRCT] vs Abbott Laboratories [ABT] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Procept BioRobotics wins in 5 metrics, Abbott Laboratories wins in 14 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricProcept BioRoboticsAbbott LaboratoriesBetter
P/E Ratio (TTM)-27.5016.43Procept BioRobotics
Price-to-Book Ratio6.844.51Abbott Laboratories
Debt-to-Equity Ratio21.0226.50Procept BioRobotics
PEG Ratio-36.1825.37Procept BioRobotics
EV/EBITDA-26.7220.46Procept BioRobotics
Profit Margin (TTM)-36.20%32.43%Abbott Laboratories
Operating Margin (TTM)-39.67%19.73%Abbott Laboratories
EBITDA Margin (TTM)N/A19.73%N/A
Return on Equity-27.62%30.93%Abbott Laboratories
Return on Assets (TTM)-13.36%6.62%Abbott Laboratories
Free Cash Flow (TTM)$-103.62M$6.35BAbbott Laboratories
Dividend Yield0.64%1.28%Abbott Laboratories
1-Year Return-25.26%21.53%Abbott Laboratories
Price-to-Sales Ratio (TTM)10.695.29Abbott Laboratories
Enterprise Value$2.43B$234.33BAbbott Laboratories
EV/Revenue Ratio9.755.44Abbott Laboratories
Gross Profit Margin (TTM)63.85%56.44%Procept BioRobotics
Revenue per Share (TTM)$5$25Abbott Laboratories
Earnings per Share (Diluted)$-1.69$7.97Abbott Laboratories
Beta (Stock Volatility)1.040.71Abbott Laboratories
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends

Procept BioRobotics vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Procept BioRobotics-3.07%-18.39%-30.51%-25.46%-43.09%-52.39%
Abbott Laboratories1.69%4.65%-1.23%-1.41%2.32%16.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Procept BioRobotics-25.26%4.46%14.23%14.23%14.23%14.23%
Abbott Laboratories21.53%18.51%32.13%163.03%450.04%491.67%

Performance & Financial Health Analysis: Procept BioRobotics vs Abbott Laboratories

MetricPRCTABT
Market Information
Market Cap i$2.66B$227.88B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i1,476,6305,718,390
90 Day Avg. Volume i1,040,5027,295,300
Last Close$38.38$134.29
52 Week Range$37.12 - $103.81$107.11 - $141.23
% from 52W High-63.03%-4.91%
All-Time High$103.81 (Nov 11, 2024)$142.60 (Dec 27, 2021)
% from All-Time High-63.03%-5.83%
Growth Metrics
Quarterly Revenue Growth0.55%0.07%
Quarterly Earnings Growth0.55%0.37%
Financial Health
Profit Margin (TTM) i-0.36%0.32%
Operating Margin (TTM) i-0.40%0.20%
Return on Equity (TTM) i-0.28%0.31%
Debt to Equity (MRQ) i21.0226.50
Cash & Liquidity
Book Value per Share (MRQ)$7.04$29.05
Cash per Share (MRQ)$5.72$4.18
Operating Cash Flow (TTM) i$-83,907,000$9.04B
Levered Free Cash Flow (TTM) i$-58,771,876$5.92B
Dividends
Last 12-Month Dividend Yield i0.64%1.28%
Last 12-Month Dividend i$0.38$1.69

Valuation & Enterprise Metrics Analysis: Procept BioRobotics vs Abbott Laboratories

MetricPRCTABT
Price Ratios
P/E Ratio (TTM) i-27.5016.43
Forward P/E i-36.1825.37
PEG Ratio i-36.1825.37
Price to Sales (TTM) i10.695.29
Price to Book (MRQ) i6.844.51
Market Capitalization
Market Capitalization i$2.66B$227.88B
Enterprise Value i$2.43B$234.33B
Enterprise Value Metrics
Enterprise to Revenue i9.755.44
Enterprise to EBITDA i-26.7220.46
Risk & Other Metrics
Beta i1.040.71
Book Value per Share (MRQ) i$7.04$29.05

Financial Statements Comparison: Procept BioRobotics vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PRCTABT
Revenue/Sales i$69.16M$10.36B
Cost of Goods Sold i$25.00M$4.47B
Gross Profit i$44.16M$5.89B
Research & Development i$16.40M$716.00M
Operating Income (EBIT) i$-27.44M$1.69B
EBITDA i$-22.39M$2.66B
Pre-Tax Income i$-24.74M$1.78B
Income Tax iN/A$453.00M
Net Income (Profit) i$-24.74M$1.33B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PRCTABT
Cash & Equivalents i$316.21M$6.53B
Total Current Assets i$465.79M$23.15B
Total Current Liabilities i$52.06M$13.00B
Long-Term Debt i$77.83M$12.74B
Total Shareholders Equity i$389.16M$49.06B
Retained Earnings i$-570.72M$47.72B
Property, Plant & Equipment i$21.26MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PRCTABT
Operating Cash Flow i$-11.65M$1.42B
Capital Expenditures i$-1.84M$-484.00M
Free Cash Flow i$-18.82M$933.00M
Debt Repayment iN/A$-1.00B
Common Stock Repurchase iN/A$-280.00M

Short Interest & Institutional Ownership Analysis

MetricPRCTABT
Shares Short i6.82M19.06M
Short Ratio i9.533.12
Short % of Float i0.15%0.01%
Average Daily Volume (10 Day) i1,476,6305,718,390
Average Daily Volume (90 Day) i1,040,5027,295,300
Shares Outstanding i54.72M1.73B
Float Shares i53.21M1.73B
% Held by Insiders i0.04%0.01%
% Held by Institutions i0.94%0.81%

Dividend Analysis & Yield Comparison: Procept BioRobotics vs Abbott Laboratories

MetricPRCTABT
Last 12-Month Dividend i$0.38$1.69
Last 12-Month Dividend Yield i0.64%1.28%
3-Year Avg Annual Dividend i$0.53$1.92
3-Year Avg Dividend Yield i0.12%0.49%
3-Year Total Dividends i$1.59$5.77
Ex-Dividend DateMar 31, 2025Jan 15, 2025